Lv46
648 积分 2024-10-28 加入
Deriving acceptable limits for non-mutagenic impurities in medicinal products – Durational adjustments
13天前
已完结
Impurities in Active Pharmaceutical Ingredients and Drug Products: A Critical Review
13天前
已完结
Safety assessment of drug impurities for patient safety: A comprehensive review
15天前
已完结
New limits proposed for the management of non-mutagenic impurities
15天前
已完结
Changing the container closure system of lyophilized products: Real or perceived risk to process efficiency and product quality?
19天前
已完结
Microscopic evaluation of pharmaceutical glass container-formulation interactions under stressed conditions
20天前
已完结
Activation energies for the decomposition of pharmaceuticals and their application to predicting hydrolytic stability in drug discovery
21天前
已完结
Bumetanide as a Model NDSRI Substrate: N-nitrosobumetanide Impurity Formation and its Inhibition in Bumetanide Tablets
22天前
已完结
Reverse engineering the Ozurdex dexamethasone intravitreal implant
22天前
已完结
Analytical Procedure Development and Proposed Established Conditions: A Case Study of a Mass Spectrometry Based NDSRI Analytical Procedure
23天前
已完结
The Dubious Effect of Milnacipran for the Treatment of Burning Mouth Syndrome
1个月前
已采纳
FIGO good practice recommendations on magnesium sulfate administration for preterm fetal neuroprotection
1个月前
已采纳
Fibers for hearts: A critical review on electrospinning for cardiac tissue engineering
1个月前
已采纳
Study of a nearly Ni-free V-containing lean duplex stainless steel and the deformation mechanism
1个月前
已采纳
皖公网安备34019202002308
